Dosage and administration
One caplet daily with or without food or as prescribed by your healthcare provider.
One caplet daily with or without food or as prescribed by your healthcare provider.
| Supplement Facts | ||
| Serving Size: 1 Tablet | ||
| Amount | % Daily | |
| Per Serving | Value | |
| Vitamin C (as Ascorbic Acid) | 500 mg | 556% |
| Vitamin E (as dl-Alpha Tocopheryl Acetate) | 13.5 mg | 90% |
| Folate (as L-5-methyltetrahydrofolate Calcium) | 1,020 mcg DFE | 255% |
| (600 mcg L-5-MTHF) | ||
| Vitamin B12 (as Cyanocobalamin) | 60 mcg | 2,500% |
| Biotin | 150 mcg | 500% |
| Iron (as Carbonyl Iron) | 150 mg | 833% |
| Copper (as Cupric Sulfate) | 3 mg | 333% |
| *Daily Value not established. |
OTHER INGREDIENTS:
Microcrystalline Cellulose, Citric Acid, Stearic Acid, Dicalcium Phosphate, Croscarmellose Sodium, Polyvinylpyrrolidone, Hypromellose, Magnesium Stearate, Silicon Dioxide, Starch, Glucose, Calcium Carbonate, Crospovidone, Isomalt, Sodium Lauryl Sulfate, Maltodextrin, Triglycerides, Sucrose, Soy Polysaccharide, Glycerin, Mineral Oil, Polyethylene Glycol, Artificial French Vanilla Flavor, Annatto Extract (color), Propylene Glycol, Tricalcium Phosphate, Potassium Hydroxide, and Talc. Contains: Soy
Contains a bioengineered food ingredient.
HEMATRON AF is a multi-vitamin / multi-mineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency†
| †This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. |
| WARNING Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately. |
DO NOT USE with individuals with a known hypersensitivity to any of the ingredients. Patients with hemochromatosis and hemosiderosis are contra-indications to iron therapy. This product is not for use in children under 12 years of age.
This product contains 1,020mcg DFE (600mcg L5-MTHF); the maximum safe Reference Daily Intake (RDI) amount for this nutrient is 1000mcg. Folic Acid in doses above 0.1 mg (1000mcg) daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive. There is a potential danger in administering folic acid to patients with undiagnosed anemia since folic acid may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia.
ADVERSE REACTIONS
Allergic sensitization has been reported following both oral and parenteral administration of Folic Acid.
One caplet daily with or without food or as prescribed by your healthcare provider.
Store at room temperature, USP.
To report a serious adverse event or to obtain product information, contact (888) 444-5072.
Manufactured in the USA for:
Seyer Pharmatec, Inc.
Caguas, Puerto Rico 00726
DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.
Dietary Supplement
EZY-DOSE TABLETS
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| LEVOMEFOLIC ACID Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20230428 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b82b4008-22fd-05f5-6cc6-c0a6e81c65b8 | Product name | 2 | 20240805 |
| 910c1bd7-67d1-44c7-ad4f-9445f827edcc | Product name | 1 | 20230808 |
| cb89b86a-369e-4204-8910-ae797c503af3 | Product name | 1 | 20230706 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| d4880ace-a516-8c47-8dfd-73a4ba5887d7 | Product name | 2 | 20180830 |
| ddff2484-d547-4e6a-bacd-95eef7e31c64 | Product name | 2 | 20180807 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 90854981-3820-4bc4-a1d3-666ec508941c | Product name | 2 | 20180214 |
| c5cd4727-ac49-4409-82b1-5bd8006c3ec7 | Product name | 1 | 20171122 |
| d206bb34-ea65-399d-70d9-834f22dc2c18 | Product name | 3 | 20170724 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11026-2761-9 | Hematron-AF | 90 in 1 BOTTLE | TABLET | 90 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11026-2761 | HEMATRON-AF (ASCORBIC ACID, DL-ALPHA TOCOPHERYL ACETATE, L-5-METHYLTETRAHYDROFOLATE CALCIUM, CYANOCOBALAMIN, BIOTIN, CARBONYL IRON, CUPRIC SULFATE) TABLET [SEYER PHARMATEC, INC.] | 1 | 1 package rows | 20240820_aca66c3e-32b9-4962-a6a0-58245fbbf242.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11026-2761 | 11026-2761-9 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ascorbic acid | ASCORBIC ACID | Zydus Pharmaceuticals USA Inc. | f0b683f8-189b-4a3f-9ffe-f91df6d798b6 | 2026-09-03 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic acid | ASCORBIC ACID | Zydus Lifesciences Limited | d2d29ffd-5483-45bb-9d1b-da7af23b3720 | 2026-09-03 | ASCORBIC ACID | |
| Ascorbic Acid | ASCORBIC ACID | Renova Pharmaceuticals LLC | a6481bae-2397-44c7-a51d-4f47ad91bd2c | 2026-08-19 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascor | ASCORBIC ACID | McGuff Pharmaceuticals, Inc. | 388aad52-fc01-4784-9791-1dbc80c69306 | 2026-05-29 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic Acid | ASCORBIC ACID | Fresenius Kabi USA, LLC | 1606e29f-0e80-4069-b688-daab9cbff20a | 2025-12-17 | Warnings, Adverse reactions | ASCORBIC ACID |
| Skin Renewing Serum | ASCORBIC ACID | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c2a8d-ac95-cbef-e063-6294a90aff39 | 2025-08-23 | Warnings | ASCORBIC ACID |
Adverse event summaries are temporarily unavailable. Other product information remains available.